Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC), from a single donor, in EGMTM-2 containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC), from pooled donors, in EGMTM-2 and containing ≥ 500,000 cells
Cryopreserved ampule of Human Human Umbilical Vein Endothelial Cells (HUVEC) from a single donor containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, cultured in EGMTM-2, pre-screened for Angiogenesis and containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) without VEGF, from a single donor, cultured in EGMTM Plus and containing ≥ 500,000 cells
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 MV Microvascular Endothelial Cell Growth Medium SingleQuotsTM supplements (CC-4147) required for growth of Microvascular Endothelial Cells
Basal media required for growth of Endothelial cells, 500 mL (supplements and growth factors sold separately)
-
White PaperSimple and easy monitoring of three different cancer-relevant assays – Tube formation assay, 2D cell migration assay and 3D cell invasion assay
-
Nucleofector™ Technology – Guideline for Easy Set Up of RNAi Screening ExperimentsThis guideline aims to help researchers in setting up a successful RNAiscreening experiment using the Nucleofector™ 96-well Shuttle™ System. The recommendations are based on our experience gained in using theNucleofector™ 96-well Shuttle™ System for screens with Thermo ScientificsiRNA libraries in difficult-to-transfect Jurkat T cells and primary HUVECcells2, combined with recommendations collected from the literature. It highlights important parameters that may influence the quality of cellbasedscreening results.
-
Endothelial Cells Concentration Guide
-
Metabolism_Brochure_CoBrand_FormThis is a co-marketing form for distributors. There is a restricted space on the cover next to the Lonza logo and on the back below the market bar. Art for placement MUST be a PDF. In addition there is space on the back cover for a web address at the top and contact and disclaimers. Please look for the instruction PDF in the literature DB Article number CD-FO006Inst
-
The Nucleofector® 96-well Shuttle System - Nucleofection® of Cell Lines and Primary Cells in an Automated FrameworkLonza WhitePaper
-
Poster - AACR 2017Simple and easy monitoring of tube formation and migration assays with the CytoSMART™ Live Cell Imaging System
-
HUV-EC-C Transfection Protocol - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of HUV-EC-C cells with the Cell Line Nucleofector™ Kit V
-
Basic Transfection Protocol for Endothel. Cells (Adh.) - 4D-Nucleofector™ DeviceInstructions of use for transfection of adherent primary mammalian endothelial cells with the AD1 Primary Cell 4D-Nucleofector™ Y Kit
-
Transfection Protocol for HMVEC-L (Lonza) - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human lung microvascular endothelial cells (Lonza) with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
TechSheet - Iliac Artery Endothelial Cell System, HIAECTechnical information sheet for Clonetics™ Iliac Artery Endothelial Cells